The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

What Has Changed in Ebola Response Since the Last Big Outbreak

The tools available to fight Ebola look very different than they did during the 2014-2016 West Africa outbreak that killed more than 11,000 people, STAT News reports in its Morning Rounds roundup. Back then, responders had no licensed vaccine and no approved drugs. Today public health agencies can deploy Merck's Ervebo vaccine and antibody treatments cleared for use, changing how quickly a flare-up can be contained.

That shift matters because speed and supply now drive outcomes as much as case detection. A faster vaccination ring strategy and proven therapeutics give responders options that did not exist a decade ago, even as logistics, funding, and local trust remain hard problems.

The same STAT briefing surfaces two other stories worth watching: a federal report on alcohol that was suppressed before release, and what STAT calls an "inevitable" development in how data from consumer wearables will be collected and used. Both point to growing tension over who controls health information and how government findings reach the public.

Sources

More in Government

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.